OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Adjuvant Glucose-Like Peptide 1 Receptor Agonist Therapy for Suboptimal Weight Loss After Bariatric Surgery: a Systematic Review
Alexandre Dréant, Claire Blanchard, David Jacobi
Obesity Surgery (2024) Vol. 34, Iss. 5, pp. 1846-1854
Closed Access | Times Cited: 8

Showing 8 citing articles:

New Generation Anti-Obesity Pharmacotherapy: Companion or Competitor to Metabolic Bariatric Surgery?
Amirhossein Sahebkar, Kishore M. Gadde, Matthew Kroh, et al.
Drug Discovery Today (2024) Vol. 29, Iss. 8, pp. 104072-104072
Closed Access | Times Cited: 3

Curbing the Obesity Epidemic: Should GLP-1 Receptor Agonists Be the Standard of Care for Obesity?
Jennifer M. Kaplan, Adnin Zaman, Layla A. Abushamat
Current Cardiology Reports (2024) Vol. 26, Iss. 9, pp. 1011-1019
Closed Access | Times Cited: 3

Adverse event comparison between glucagon‐like peptide‐1 receptor agonists and other antiobesity medications following bariatric surgery
Jason M. Samuels, Kevin D. Niswender, Christianne L. Roumie, et al.
Diabetes Obesity and Metabolism (2024) Vol. 26, Iss. 9, pp. 3906-3913
Open Access | Times Cited: 1

Assessment and medical management of weight regain after adolescent metabolic and bariatric surgery: a narrative review
Alaina P. Vidmar, Courtney E. Batt, Jaime M. Moore
Surgery for Obesity and Related Diseases (2024) Vol. 21, Iss. 1, pp. 24-32
Closed Access | Times Cited: 1

Adverse Event Comparison between Glucagon-like Peptide-1 Receptor Agonists and Other Anti-Obesity Medications Following Bariatric Surgery
Jason M. Samuels, Kevin D. Niswender, Christianne L. Roumie, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access

Spezielle Aspekte in der Adipositas- und metabolischen Chirurgie
Darick Fidan, Christine Stier, L. Schäfer, et al.
Allgemein- und Viszeralchirurgie up2date (2024) Vol. 18, Iss. 04, pp. 329-347
Closed Access

Should GLP-1 Agonists Be Considered an Alternative or Adjunct to Pediatric Metabolic and Bariatric Surgery? More Questions Than Answers
Marc P. Michalsky, Claudia K. Fox, Janey S.A. Pratt
Surgery for Obesity and Related Diseases (2024)
Closed Access

Page 1

Scroll to top